References
[1] Staskin D, Kelleher C, Avery K, Bosch R, Cotterill N, Coyne K, et al. Initial assessment of urinary and faecal incontinence in adult male and female patients. In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence. 4th ed. Plymouth: Health Publications; 2009.
[2] Tikkinen KA, Johnson TM, Tammela TL, Sintonen H, Haukka J, Huhtala H, et al. Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. Eur Urol. 2010;57:488–96. [PubMed]
[3] Chartier-Kastler E, Tubaro A. The measurement of nocturia and its impact on quality of sleep and quality of life in LUTS/BPH. Eur Urol Suppl. 2006;5:3–11.
[4] Weiss JP, Blaivas JG. Nocturia. J Urol. 2000;163:5–12. [PubMed]
[5] Udo Y, Nakao M, Honjo H, Ukimura O, Kawauchi A, Kitakoji H, et al. Analysis of nocturia with 24-h urine volume, nocturnal urine volume, nocturnal bladder capacity and length of sleep duration: concept for effective treatment modality. BJU Int. 2011;107:791–8. [PubMed]
[6] Weiss JP, Blaivas JG, Stember DS, Chaikin DC. Evaluation of the etiology of nocturia in men: the nocturia and nocturnal bladder capacity indices. Neurourol Urodyn. 1999;18:559–65. [PubMed]
[7] Walmsley K, Staskin DR. Nocturia: when is it not related to overactive bladder? Curr Urol Rep. 2003;4:441–5. [PubMed]
[8] Mariappan P, Turner KJ, Sothilingam S, Rajan P, Sundram M, Stewart LH. Nocturia, nocturia indices and variables from frequency–volume charts are significantly different in Asian and Caucasian men with lower urinary tract symptoms: a prospective comparison study. BJU Int. 2007;100:332–6. [PubMed]
[9] Burton C, Weiss JP, Parsons M, Blaivas JG, Coats AC. Reference values for the nocturnal bladder capacity index. Neurourol Urodyn. 2011;30:52–7. [PubMed]
[10] Sigurdsson S, Ogmundsdottir HM, Gudbjarnason S. Antiproliferative effect of Angelica archangelicafruits. Z Naturforsch C. 2004;59:523–7. [PubMed]
[11] Sigurdsson S, Ogmundsdottir HM, Gudbjarnason S. The cytotoxic effect of two chemotypes of essential oils from the fruits of Angelica archangelica L. Anticancer Res. 2005;25:1877–80. [PubMed]
[12] Härmälä P, Vuorela H, Törnquist K, Hiltunen R. Choice of solvent in the extraction of Angelica archangelica roots with reference to calcium blocking activity. Planta Med. 1992;58:176–83. [PubMed]
[13] Halldórsson B. Grasnytjar. Copenhagen: August Friedrich Stein; 1783.
[14] Bjarnason AH. Íslensk flóra með litmyndum. Reykjavík: Iðunn; 1983.
[15] Newall CA, Anderson LA, Phillipson JD. Herbal medicines – a guide for health-care professionals.London: Pharmaceutical Press; 1996.
[16] Sigurdsson S, Ogmundsdottir HM, Hallgrimsson J, Gudbjarnason S. Antitumour activity of Angelica archangelica leaf extract. In Vivo. 2005;19:191–4. [PubMed]
[17] Piper PJ. Leukotrienes: possible mediators in bronchial asthma. Eur J Respir Dis Suppl. 1983;129:45–64. [PubMed]
[18] Bjorling DE, Saban MR, Bruskewitz RC, Saban R. Response of the isolated guinea pig bladder to exogenous and endogenous leukotrienes. J Urol. 1994;152:1281–6. [PubMed]
[19] Yoshimura N, Chancellor MB. Interstitial cystitis and bladder research: progress and future directions: highlights of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Interstitial Cystitis Association (ICA) International Research Symposium October 19–20, 2000, Minneapolis, MN. Rev Urol. 2001;3:146–51. [PMC free article] [PubMed]
[20] Scheuermaier K, Meyers M, Surprise M, Loughlin KR, Duffy JF. Reciprocal relationship between age-related sleep disruption and urological symptoms. BJU Int. 2011;107:871–3. [PMC free article][PubMed]
Recent Comments